Breast cancer: Clinical Practice Guidelines in Oncology™

Robert W. Carlson, D. Craig Alfred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Mohammad Jahanzeb, Krystyna Kiel, Britt Marie Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lisle M. Nabell, Lori J. PierceElizabeth C. Reed, Mary Lou Smith, George Somlo, Richard L. Theriault, Neal S. Topham, John H. Ward, Eric P. Winer, Antonio C. Wolff

Research output: Contribution to journalArticle

326 Citations (Scopus)

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

Original languageEnglish (US)
Pages (from-to)122-192
Number of pages71
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Practice Guidelines
Breast Neoplasms
Clinical Trials
Physicians
Therapeutics
Patient Participation
Guidelines
Neoplasms

Keywords

  • Adjuvant therapy
  • Breast cancer
  • Breast-conserving therapy
  • Chemotherapy
  • Ductal carcinoma in situ
  • Endocrine therapy
  • Lobular carcinoma in situ
  • Mastectomy
  • NCCN clinical practice guidelines
  • Radiation
  • Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Carlson, R. W., Alfred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., ... Wolff, A. C. (2009). Breast cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 7(2), 122-192. https://doi.org/10.6004/jnccn.2009.0012

Breast cancer : Clinical Practice Guidelines in Oncology™. / Carlson, Robert W.; Alfred, D. Craig; Anderson, Benjamin O.; Burstein, Harold J.; Carter, W. Bradford; Edge, Stephen B.; Erban, John K.; Farrar, William B.; Goldstein, Lori J.; Gradishar, William J.; Hayes, Daniel F.; Hudis, Clifford A.; Jahanzeb, Mohammad; Kiel, Krystyna; Ljung, Britt Marie; Marcom, P. Kelly; Mayer, Ingrid A.; McCormick, Beryl; Nabell, Lisle M.; Pierce, Lori J.; Reed, Elizabeth C.; Smith, Mary Lou; Somlo, George; Theriault, Richard L.; Topham, Neal S.; Ward, John H.; Winer, Eric P.; Wolff, Antonio C.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 7, No. 2, 02.2009, p. 122-192.

Research output: Contribution to journalArticle

Carlson, RW, Alfred, DC, Anderson, BO, Burstein, HJ, Carter, WB, Edge, SB, Erban, JK, Farrar, WB, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, CA, Jahanzeb, M, Kiel, K, Ljung, BM, Marcom, PK, Mayer, IA, McCormick, B, Nabell, LM, Pierce, LJ, Reed, EC, Smith, ML, Somlo, G, Theriault, RL, Topham, NS, Ward, JH, Winer, EP & Wolff, AC 2009, 'Breast cancer: Clinical Practice Guidelines in Oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 2, pp. 122-192. https://doi.org/10.6004/jnccn.2009.0012
Carlson, Robert W. ; Alfred, D. Craig ; Anderson, Benjamin O. ; Burstein, Harold J. ; Carter, W. Bradford ; Edge, Stephen B. ; Erban, John K. ; Farrar, William B. ; Goldstein, Lori J. ; Gradishar, William J. ; Hayes, Daniel F. ; Hudis, Clifford A. ; Jahanzeb, Mohammad ; Kiel, Krystyna ; Ljung, Britt Marie ; Marcom, P. Kelly ; Mayer, Ingrid A. ; McCormick, Beryl ; Nabell, Lisle M. ; Pierce, Lori J. ; Reed, Elizabeth C. ; Smith, Mary Lou ; Somlo, George ; Theriault, Richard L. ; Topham, Neal S. ; Ward, John H. ; Winer, Eric P. ; Wolff, Antonio C. / Breast cancer : Clinical Practice Guidelines in Oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2009 ; Vol. 7, No. 2. pp. 122-192.
@article{e6c8ed8e2ad1412d926a97cb67d5cc2c,
title = "Breast cancer: Clinical Practice Guidelines in Oncology™",
abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.",
keywords = "Adjuvant therapy, Breast cancer, Breast-conserving therapy, Chemotherapy, Ductal carcinoma in situ, Endocrine therapy, Lobular carcinoma in situ, Mastectomy, NCCN clinical practice guidelines, Radiation, Therapy",
author = "Carlson, {Robert W.} and Alfred, {D. Craig} and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Carter, {W. Bradford} and Edge, {Stephen B.} and Erban, {John K.} and Farrar, {William B.} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Hudis, {Clifford A.} and Mohammad Jahanzeb and Krystyna Kiel and Ljung, {Britt Marie} and Marcom, {P. Kelly} and Mayer, {Ingrid A.} and Beryl McCormick and Nabell, {Lisle M.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Smith, {Mary Lou} and George Somlo and Theriault, {Richard L.} and Topham, {Neal S.} and Ward, {John H.} and Winer, {Eric P.} and Wolff, {Antonio C.}",
year = "2009",
month = "2",
doi = "10.6004/jnccn.2009.0012",
language = "English (US)",
volume = "7",
pages = "122--192",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Breast cancer

T2 - Clinical Practice Guidelines in Oncology™

AU - Carlson, Robert W.

AU - Alfred, D. Craig

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Carter, W. Bradford

AU - Edge, Stephen B.

AU - Erban, John K.

AU - Farrar, William B.

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford A.

AU - Jahanzeb, Mohammad

AU - Kiel, Krystyna

AU - Ljung, Britt Marie

AU - Marcom, P. Kelly

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Nabell, Lisle M.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Smith, Mary Lou

AU - Somlo, George

AU - Theriault, Richard L.

AU - Topham, Neal S.

AU - Ward, John H.

AU - Winer, Eric P.

AU - Wolff, Antonio C.

PY - 2009/2

Y1 - 2009/2

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

KW - Adjuvant therapy

KW - Breast cancer

KW - Breast-conserving therapy

KW - Chemotherapy

KW - Ductal carcinoma in situ

KW - Endocrine therapy

KW - Lobular carcinoma in situ

KW - Mastectomy

KW - NCCN clinical practice guidelines

KW - Radiation

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=60749097820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749097820&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2009.0012

DO - 10.6004/jnccn.2009.0012

M3 - Article

C2 - 19200416

AN - SCOPUS:60749097820

VL - 7

SP - 122

EP - 192

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 2

ER -